News | May 15, 2023
Briefs: Dr. Reddy's Laboratories and Max Healthcare Institute
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The collaboration between CORONA and Ferring will cater to patients across India
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
The partnership will capitalize on the combined capabilities of the two organizations
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
Subscribe To Our Newsletter & Stay Updated
